Skip to main content

Transgenomic Teams With MCW to Offer NGS Testing Services

NEW YORK (GenomeWeb News) – Transgenomic and the Medical College of Wisconsin today announced an agreement under which Transgenomic will offer next-generation sequencing-based testing from the MCW Clinical Sequencing Program.

Services offered under the collaboration will include Transgenomic's NuclearMitome test for mitochondrial disorders. The test uses NGS technology for the identification of 448 genes that are considered important for mitochondrial function, and according to Transgenomic, it represents the most comprehensive genetic test for such disorders. The MCW laboratory will become the first to offer the test.

Financial and other terms of the deal were not disclosed.

"This collaboration allows Transgenomic to rapidly expand the commercial use of our NuclearMitome test in addition to building out our offerings in whole-genome and exome testing," Transgenomc CEO Craig Tuttle said in a statement.

Howard Jacob, director of the Human and Molecular Genetics Center at MCW added, "The ability to evaluate 400-plus genes with one diagnostic tool should shorten patients' diagnostic odysseys and provide faster answers."

The Scan

UK Funds to Stay Ahead of Variants

The UK has announced a further £29.3 million to stay on top of SARS-CoV-2 variants, the Guardian reports.

Push for Access

In a letter, researchers in India seek easier access to COVID-19 data, Science reports.

Not as Cold

Late-stage trial results are expected soon for an RNA-based vaccine that could help meet global demand as it does not require very cold storage, the New York Times writes.

Genome Research Papers on Microbes' Effects on Host Transfer RNA, Honeybee Evolution, Single-Cell Histones

In Genome Research this week: influence of microbes on transfer RNA patterns, evolutionary relationships of honeybees, and more.